FDA Rejects Keytruda-Lenvima Combo as First-line Treatment for Liver Cancer
News
The U.S. Food and Drug Administration (FDA) has issued a complete response letter stating that it will not approve the combination of Keytruda (pembrolizumab) plus Lenvima (lenvatinib) as a first-line treatment for people ... Read more